Liberty Leaf Announces Completion of CBD Research Study on Canine Pain Management

Vancouver, B.C. August 20, 2018: Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) (“Liberty Leaf” or the “Company) is pleased to announce the completion of its first CBD research trial on pain medication for...

Read More